Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

HVTN 505 is a preventative vaccine efficacy trial testing DNA followed by recombinant adenovirus serotype 5 (rAd5) in circumcised, Ad5-seronegative men and transgendered persons who have sex with men in the United States. Identified immune correlates of lower HIV-1 risk and a virus sieve analysis re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Neidich, Scott D., Fong, Youyi, Li, Shuying S., Geraghty, Daniel E., Williamson, Brian D., Young, William Chad, Goodman, Derrick, Seaton, Kelly E., Shen, Xiaoying, Sawant, Sheetal, Zhang, Lu, deCamp, Allan C., Blette, Bryan S., Shao, Mengshu, Yates, Nicole L., Feely, Frederick, Pyo, Chul-Woo, Ferrari, Guido, Frank, Ian, Karuna, Shelly T., Swann, Edith M., Mascola, John R., Graham, Barney S., Hammer, Scott M., Sobieszczyk, Magdalena E., Corey, Lawrence, Janes, Holly E., McElrath, M. Juliana, Gottardo, Raphael, Gilbert, Peter B., Tomaras, Georgia D.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6819135/
https://ncbi.nlm.nih.gov/pubmed/31589165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI126391
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados